Trial site
University of North Carolina Medical Center
- 20running trials
- 8closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes10 trials
- Metastatic breast cancer3 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Vitiligo2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Gastric and oesophageal cancer1 trial
- Gastroparesis1 trial
- Heart failure1 trial
- Lung cancer1 trial
- and 5 more
- Phase
- Phase 317 trials
- Phase 25 trials
- Phase 2/33 trials
- Status
- Active, not recruiting12 trials
- Recruiting7 trials
- Completed5 trials
- Withdrawn2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company14 trials
- Bristol-Myers Squibb3 trials
- Pfizer3 trials
- Emory University1 trial
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial
- and 6 more
Running trials
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Active, not recruiting
Active, not recruiting
Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Stroke2 recruiting
- Type 2 diabetes2 recruiting
- Atrial fibrillation1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Withdrawn
Completed
Completed
Terminated
Completed
Completed
Recruiting
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 19 Nov 2026